This inventor holds 1 USPTO granted patent. Top assignee: K.v. Pharmaceutical Company. Active years: 1996.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1996
Title: Ronald S. Harland: Innovator in Pharmaceutical Delivery Systems
Introduction
Ronald S. Harland is a notable inventor based in Chesterfield, MO (US). He has made significant contributions to the field of pharmaceuticals, particularly in developing innovative delivery systems. His work focuses on creating tasteless pharmaceutical materials that enhance patient compliance and experience.
Latest Patents
Harland holds a patent for a "Tastemasked pharmaceutical materials." This invention presents a substantially tasteless pharmaceutical delivery system, which comprises an active material and a spatially oriented matrix. The matrix includes a wax core material with a melting point ranging from about 50°C to about 200°C, along with a regional hydrophobic polymer material. This innovative approach aims to improve the palatability of medications, making them easier for patients to consume.
Career Highlights
Harland is associated with K.V. Pharmaceutical Company, where he has been instrumental in advancing pharmaceutical technologies. His expertise in creating effective delivery systems has positioned him as a valuable asset in the industry. With a focus on patient-centered solutions, he continues to contribute to the development of innovative pharmaceutical products.
Collaborations
Throughout his career, Harland has collaborated with notable colleagues, including R. Saul Levinson and Robert C. Cuca. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas within the pharmaceutical sector.
Conclusion
In summary, Ronald S. Harland is a distinguished inventor whose work in tastemasked pharmaceutical materials has made a significant impact on the industry. His dedication to improving patient experiences through innovative delivery systems showcases his commitment to advancing pharmaceutical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile